Surprisingly, patients in the fourth clinical stage of CRC have a higher level of serum IL-10 when compared to lower stages, while a high serum concentration of IL-10 correlates with poor survival of patients with CRC [121,122]. Here, IL10 is linked to colorectal carcinoma.